H.U. Group Holdings

Update in progress

4544.T (Tokyo)

H.U. Group Holdings, Inc. and its subsidiaries operate healthcare businesses in Japan, the U.S., Europe and worldwide. The Lab Testing segment provides general and esoteric medical testing, cancer diagnostics, omics analyses, clinical-trial support, specimen handling and data management, plus clinician SaaS and personal health records. The In-Vitro Diagnostics segment sells Lumipulse systems, supports neurodegenerative and rapid infectious-disease testing, and biomarkers. The Healthcare-related Services segment covers hospital sterilization, operating room support, equipment maintenance, logistics, medical-supply sales, and home care. Formerly Miraca Holdings; renamed in 2020. Based in Tokyo, founded 1950.